Fidelity Investments’s La Jolla Pharmaceutical Company LJPC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-90,310
| Closed | -$288K | – | 5675 |
|
|
2022
Q2 | $288K | Sell |
90,310
-131
| -0.1% | -$510 | ﹤0.01% | 3026 |
|
|
2022
Q1 | $386K | Buy |
+90,441
| New | +$394K | ﹤0.01% | 3066 |
|
|
2021
Q4 | – | Sell |
-1,000
| Closed | -$4K | – | 5268 |
|
|
2021
Q3 | $4K | Buy |
1,000
+500
| +100% | +$1.99K | ﹤0.01% | 3888 |
|
|
2021
Q2 | $2K | Buy |
+500
| New | +$2.14K | ﹤0.01% | 3983 |
|
|
2021
Q1 | – | Sell |
-52
| Closed | – | – | 4828 |
|
|
2020
Q4 | $0 | Sell |
52
-26,433
| -100% | -$113K | ﹤0.01% | 4506 |
|
|
2020
Q3 | $107K | Sell |
26,485
-74,500
| -74% | -$309K | ﹤0.01% | 2783 |
|
|
2020
Q2 | $430K | Sell |
100,985
-1,154,004
| -92% | -$7.03M | ﹤0.01% | 2528 |
|
|
2020
Q1 | $5.27M | Sell |
1,254,989
-29
| -0% | -$183 | ﹤0.01% | 1923 |
|
|
2019
Q4 | $4.93M | Sell |
1,255,018
-2,809,798
| -69% | -$16.6M | ﹤0.01% | 2053 |
|
|
2019
Q3 | $35.8M | Hold |
4,064,816
| – | – | ﹤0.01% | 1334 |
|
|
2019
Q2 | $37.6M | Buy |
4,064,816
+3,391
| +0.1% | +$25.6K | ﹤0.01% | 1355 |
|
|
2019
Q1 | $26.1M | Buy |
4,061,425
+128,074
| +3% | +$834K | ﹤0.01% | 1474 |
|
|
2018
Q4 | $37.1M | Sell |
3,933,351
-290
| -0% | -$4.36K | 0.01% | 1287 |
|
|
2018
Q3 | $79.2M | Buy |
3,933,641
+275,957
| +8% | +$7.21M | 0.01% | 1052 |
|
|
2018
Q2 | $107M | Buy |
3,657,684
+54,986
| +2% | +$1.7M | 0.01% | 920 |
|
|
2018
Q1 | $107M | Buy |
3,602,698
+280,912
| +8% | +$9.06M | 0.01% | 953 |
|
|
2017
Q4 | $107M | Buy |
3,321,786
+3,268
| +0.1% | +$107K | 0.01% | 964 |
|
|
2017
Q3 | $115M | Buy |
3,318,518
+5,200
| +0.2% | +$167K | 0.01% | 905 |
|
|
2017
Q2 | $98.6M | Buy |
3,313,318
+18,883
| +0.6% | +$541K | 0.01% | 988 |
|
|
2017
Q1 | $98.3M | Buy |
3,294,435
+556,334
| +20% | +$14.2M | 0.01% | 1003 |
|
|
2016
Q4 | $48M | Hold |
2,738,101
| – | – | 0.01% | 1317 |
|
|
2016
Q3 | $65.1M | Buy |
2,738,101
+117,775
| +4% | +$2.22M | 0.01% | 1185 |
|
|
2016
Q2 | $41.9M | Sell |
2,620,326
-34,333
| -1% | -$616K | 0.01% | 1352 |
|
|
2016
Q1 | $55.5M | Sell |
2,654,659
-81,567
| -3% | -$1.45M | 0.01% | 1206 |
|
|
2015
Q4 | $73.9M | Buy |
2,736,226
+66,100
| +2% | +$1.8M | 0.01% | 1097 |
|
|
2015
Q3 | $74.2M | Buy |
2,670,126
+382,500
| +17% | +$12.1M | 0.01% | 1084 |
|
|
2015
Q2 | $56.1M | Buy |
2,287,626
+381,459
| +20% | +$7.86M | 0.01% | 1293 |
|
|
2015
Q1 | $34.9M | Buy |
1,906,167
+799,526
| +72% | +$16.2M | ﹤0.01% | 1498 |
|
|
2014
Q4 | $20.4M | Hold |
1,106,641
| – | – | ﹤0.01% | 1717 |
|
|
2014
Q3 | $10.6M | Buy |
1,106,641
+625,000
| +130% | +$6.22M | ﹤0.01% | 1987 |
|
|
2014
Q2 | $4.42M | Buy |
481,641
+268,068
| +126% | +$2.45M | ﹤0.01% | 2267 |
|
|
2014
Q1 | $2.31M | Buy |
+213,573
| New | +$2.1M | ﹤0.01% | 2361 |
|
Fidelity Investments's LJPC Position: Q3 2022 in Review
Fidelity Investments sold out of La Jolla Pharmaceutical Company (LJPC) in Q3 2022, closing a stake of 90,310 shares — an estimated $288K sold.
Fidelity Investments first reported a position in LJPC in Q1 2014 and held it in 32 quarters. The position peaked at $115M in Q3 2017. 0 funds tracked by Wall St. Rank hold LJPC as of Q3 2022.
- Fidelity Investments reported no remaining La Jolla Pharmaceutical Company position as of Q3 2022 after selling out during the quarter.
- Fidelity Investments sold 90,310 La Jolla Pharmaceutical Company shares in Q3 2022, an estimated $288K.
- Fidelity Investments first reported a position in La Jolla Pharmaceutical Company in Q1 2014 and held it in 32 quarters.
- Fidelity Investments's La Jolla Pharmaceutical Company position peaked at $115M in Q3 2017.
- 0 funds tracked by Wall St. Rank held La Jolla Pharmaceutical Company as of Q3 2022.
Based on Fidelity Investments's 13F filing for Q3 2022, filed 10 Nov 2022.